Eur Rev Med Pharmacol Sci 2016; 20 (19): 3987-3991

Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival

Y.-F. Wang, S. Zhang, X.-Q. Li, Y. Wang

Department of Gynaecology and Obstetrics, Henan Provincial People’s Hospital and Zhengzhou University People’s Hospital, Zhengzhou, China. wyf901@126.com


OBJECTIVE: To investigate Long non-coding RNA HULC (HULC) expression in cervical cancer and to evaluate its clinical significance.

PATIENTS AND METHODS: HULC expression in 244 pairs of human cervical cancer and adjacent normal tissues was detected by real-time quantitative RT-PCR assay. The correlation between HULC and clinicopathological factors was also evaluated. The clinical and prognostic significance of HULC expression was analyzed statistically by Kaplan-Meier estimate and Cox regression model.

RESULTS: HULC expression was high in cervical cancer (p < 0.01). Also, the high HULC expression was significantly associated with the FIGO stage, lymph node metastasis and depth of cervical invasion (p < 0.05). Kaplan-Meier analysis showed that cervical cancer pa¬tients with high expression of HULC possessed poorer outcome than those with low expression of HULC (p < 0.001). Based on the univariate and multivariate analysis, the elevated expression of the HULC protein was a significant predictor of poor prognosis for cervical cancer patients (p = 0.001).

CONCLUSIONS: Our data firstly showed that the expression of HULC was upregulated in cervical cancer, and associated with overall survival, indicating that HULC may serve as a predictive biomarker for the prognosis of cervical cancer.

Free PDF Download

To cite this article

Y.-F. Wang, S. Zhang, X.-Q. Li, Y. Wang
Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 19
Pages: 3987-3991